Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q2 2014 · 10-Q
Revenue$935.00K$935.00K−33.6% vs Q2 2013 Net Income-$11.83M-$11.83MN/M vs Q2 2013 EPS Diluted-$0.15-$0.15N/M vs Q2 2013 Gross Profit$169,000−78.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$9,175,000N/M Free Cash Flowderived-$9,355,000N/M Margins · derivedGross margin18.1%−38.7 pt vs Q2 2013
Operating margin-1142.8%−690.9 pt vs Q2 2013
Net margin-1265.0%−1037.0 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 11, 2014 · 42 d after period end